NEORA — 1884878

Toolbar

Details

Application number

1884878

Type(s)

Standard Characters

Category

Trademark

CIPO Status

OPPOSED

TM5 status

LIVE/APPLICATION/ Opposition Pending
The pending trademark application has been examined by the Office and was published for opposition, at which time one or more oppositions were filed but they have not yet been decided.

Filed

2018-02-26

Current owner

CGTN C.V.
Abraham de Veerstraat 2
Willemstad
CURAÇAO

Agent

SMART & BIGGAR LP
SUITE 1000, 55 METCALFE STREET
P.O. BOX 2999, STATION D
Ottawa
ONTARIO K1P5Y6

Applicant

Neora Switzerland Holding GmbH
4006 Beltline Road #100
Addison, TX 75001
UNITED STATES OF AMERICA

Old Owner

Neora Switzerland Holding GmbH
4006 Beltline Road #100
Addison, TX 75001
UNITED STATES OF AMERICA

OPPONENT

Pharma Cosmetics Laboratories Ltd.
4 Nirim St. 6706041
Tel Aviv,
IL

Agent

CASSAN MACLEAN IP AGENCY INC.
190 O'CONNOR STREET
SUITE 710
OTTAWA
ONTARIO
K2P2R3

Documents

Index headings

  • NEORA

Goods (Nice class & Statement)

3
(1) Cosmetic products, namely, non-medicated skin care preparations, namely, facial scrubs, facial creams, skin creams, cleansing creams, body, hand, and skin cleansing preparations, all of the foregoing to be sold and distributed through independent consultants through direct sales marketing channels; face and body lotions to be sold and distributed through independent consultants through direct sales marketing channels; hand lotions to be sold and distributed through independent consultants through direct sales marketing channels; skin moisturizers to be sold and distributed through independent consultants through direct sales marketing channels; skin emollients to be sold and distributed through independent consultants through direct sales marketing channels; eye creams to be sold and distributed through independent consultants through direct sales marketing channels; masks, namely, beauty masks, facial masks, skin masks, all of the foregoing to be sold and distributed through independent consultants through direct sales marketing channels; face and body lotions to be sold and distributed through independent consultants through direct sales marketing channels; body oils to be sold and distributed through independent consultants through direct sales marketing channels; non-medicated lip balms to be sold and distributed through independent consultants through direct sales marketing channels; hard and liquid soaps for hands, face and body to be sold and distributed through independent consultants through direct sales marketing channels; perfumes to be sold and distributed through independent consultants through direct sales marketing channels; essential oils for skin and hair care use to be sold and distributed through independent consultants through direct sales marketing channels; dentifrices to be sold and distributed through independent consultants through direct sales marketing channels; skin and hair care cleaning preparations to be sold and distributed through independent consultants through direct sales marketing channels
5
(2) Dietary and nutritional supplements to improve brain health, sleep, and overall health and wellness to be sold and distributed through independent consultants through direct sales marketing channels; dietary food supplements to defend against free radical damage and support the immune system to be sold and distributed through independent consultants through direct sales marketing channels; health food supplements to balance PH levels, and support the immune system to be sold and distributed through independent consultants through direct sales marketing channels; protein supplements to be sold and distributed through independent consultants through direct sales marketing channels; nutritional supplements to defend against free radical damage and improve overall health to be sold and distributed through independent consultants through direct sales marketing channels; medicated cosmetic products containing antioxidants and vitamins, namely, anti-aging creams, anti-wrinkle creams, cosmetic creams to combat the signs of aging and improve skin brightness and protect the skin, facial cosmetic masks to remove dirt and oil and improve the skin, eye creams for moisturizing skin, gel eye masks to improve hydration, all of the foregoing to be sold and distributed through independent consultants through direct sales marketing channels; medicated skin care preparations containing antioxidants and vitamins, namely, creams, lotions, gels, and serums for cosmetic use to improve the condition of skin by hydrating the skin, and protecting the skin from sun damage and reduce the risk of skin cancer, all of the foregoing to be sold and distributed through independent consultants through direct sales marketing channels; medicated skin care preparations containing antioxidants and vitamins, namely creams, lotions, gels, toners, cleansers, peels that protect the skin from aging and improve the skin's condition, all of the foregoing to be sold and distributed through independent consultants through direct sales marketing channels

Claims

  • Priority Filing Date: February 13, 2018, Country or Office: UNITED STATES OF AMERICA, Application No. 87/796251 in association with the same kind of goods

Recordals (known also as Footnotes)


CHANGE IN TITLE / CHANGEMENT EN TITRE:
TYPE OF CHANGE / GENRE DE CHANGEMENT: Name / Nom
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2020-12-15
DATE OF CHANGE / DATE DE CHANGEMENT: 2019-01-24
COMMENTS / COMMENTAIRES: FROM: Nerium International Switzerland GmbH
TO: Neora Switzerland Holding GmbH
Voir Preuve au dossier/See evidence on File No. 1884878
CHANGE IN TITLE / CHANGEMENT EN TITRE:
TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2020-12-15
DATE OF CHANGE / DATE DE CHANGEMENT: 2020-08-21
COMMENTS / COMMENTAIRES: FROM: Neora Switzerland Holding GmbH
TO: CGTN C.V.
Voir Preuve au dossier/See evidence on File No. 1884878

Action History

Actions
Action Action date Due date Comments
Filed 2018-02-26
Created 2018-02-26
Formalized 2018-03-01
Search Recorded 2019-07-05
Examiner's First Report 2019-07-05 2020-01-05
Extension of Time 2020-01-16 2020-07-05 Request Letter Date: 2020/01/06
Agent Changed 2020-05-26 From: 3927 To: 10425
Amendment to Application 2020-12-15 Name / Voir Preuve au dossier/See evidence on File No. 1884878
Change of Title Registered 2020-12-15 Assignment / Voir Preuve au dossier/See evidence on File No. 1884878
Correspondence Created 2021-01-29 2021-07-29
Approved 2021-09-01 APPROVED BY PROGRAM EX200M1
Approval Notice Sent 2021-09-01 APPROVED BY PROGRAM EX200M1
Advertised 2021-09-29 Vol.68 Issue 3492
Proposed Opposition 2021-11-29
Opposed 2022-03-28 S/O filed electronically
Agent Name Changed 2023-09-29

Opposition History

Case # 1 : Pharma Cosmetics Laboratories Ltd. - Active

General Actions - Opposition

Action Action date Due date
Agent Changed 2022-03-25
Agent Changed 2023-02-22

Statement of Opposition

Action Action date Due date
Extension of Time Granted to Opponent 2021-11-29 2022-03-29
S/O Filed 2022-03-28
S/O Fee Received 2022-03-28
S/O Forwarded for Review 2022-03-29
S/O Sent to Applicant 2022-03-30 2022-05-30

Counter Statement

Action Action date Due date
C/S Served on Opponent 2022-05-30 2023-04-30
C/S Filed by Applicant 2022-05-30

Evidence - Opponent

Action Action date Due date
Extension of Time Granted to Opponent 2022-09-29
Extension of Time Granted to Opponent - Cooling-off 2022-12-13
Evidence Filed by Opponent 2023-05-01
Evidence Served on Applicant 2023-05-01 2024-10-05

Evidence - Applicant

Action Action date Due date
Administrative Delay 2023-06-14
Administrative Delay 2023-10-30
Administrative Delay 2024-01-08
Administrative Delay 2024-02-22
Administrative Delay 2024-02-28
Correspondence Created 2024-06-06 2024-06-27
Correspondence Created 2024-06-06
Correspondence Created 2024-06-21 2024-07-12
Note to File 2024-06-21 2024-06-27
Administrative Delay 2024-06-21
Correspondence Created 2024-07-11
Administrative Delay 2024-08-06
Correspondence Created 2024-08-20
Extension of Time Granted to Applicant 2024-09-23
Evidence Served on Opponent 2024-10-07 2025-07-07
Evidence Filed by Applicant 2024-10-07

Reply Evidence

Action Action date Due date
Administrative Delay 2024-12-27
Administrative Delay 2025-03-27
Administrative Delay 2025-05-07
Administrative Delay 2025-06-23
Reply Evidence Filed by Opponent 2025-07-07
Reply Evidence Served on Applicant 2025-07-07

Amended Application

Action Action date Due date
Amendment to Goods/Services Received 2025-01-13
Correspondence Created 2025-01-14
Application Amended 2025-01-14
Amended Application - Accepted 2025-01-14

Oral Hearing

Action Action date Due date
Deadline to Request Oral Hearing 2026-03-30 2026-04-30

Written Arguments - Opponent

Action Action date Due date
Written Argument Requested - Opponent 2025-09-25 2025-12-25
Extension of Time Granted to Opponent 2025-11-20
Written Argument Filed by Opponent 2025-12-29
Written Argument/Statement Served on Applicant 2025-12-29 2026-03-28

Written Arguments - Applicant

Action Action date Due date
Extension of Time Granted to Applicant 2026-02-25
Written Argument/Statement Served on Opponent 2026-03-30 2026-04-30
Written Argument Filed by Applicant 2026-03-30

Leave Evidence - Opponent

Action Action date Due date
Leave Evidence Served on Applicant 2023-11-16
Leave Evidence Filed by Opponent 2023-11-16
Correspondence Created 2023-11-28 2023-12-19
Note to File 2024-01-25
Leave Evidence Accepted from Opponent 2024-02-07
Correspondence Created 2024-02-07 2024-02-28

Cross Examination by Opponent

Action Action date Due date
Cross Examination Order on Applicant 2024-11-07 2025-05-07
Correspondence Created 2024-11-07
Cross Examination Letter Sent to Applicant - 4 + 4 Months 2024-11-07
Extension of Time Granted to Opponent 2024-12-27
Correspondence Created 2025-03-07 2025-03-28
Extension of Time Granted to Opponent 2025-03-27
Cross Examination Transcripts Served by Opponent 2025-05-07 2025-06-07
Cross Examination Transcripts Filed by Opponent 2025-05-07
No Cross Examination Undertakings 2025-06-07

Cross Examination by Applicant

Action Action date Due date
Cross Examination of Opponent Requested 2023-06-13
Correspondence Created 2023-06-14
Cross Examination Order on Opponent 2023-06-14 2024-02-28
Cross Examination Letter Sent to Opponent - 4 + 4 Months 2023-06-14
Correspondence Created 2023-10-30
Extension of Time Granted to Applicant 2023-10-30
Extension of Time Granted to Applicant 2024-01-08
Extension of Time Granted to Applicant 2024-02-22
Cross Examination of Opponent Requested - Leave Evidence 2024-02-27
Correspondence Created 2024-02-28
Cross Examination Order on Opponent - Leave Evidence 2024-02-28 2024-06-28
Extension of Time Granted to Applicant 2024-04-26
Administrative Delay 2024-04-26
Cross Examination Transcripts Filed by Applicant - Leave Evidence 2024-06-21
Cross Examination Transcripts Served by Applicant - Leave Evidence 2024-06-21 2024-07-21
No Cross Examination Undertakings 2024-07-21
Date modified: